Science
Mechanism of Action
This ingredient operates through multiple pathways: it reduces inflammation, combats bacterial proliferation (including *Staphylococcus aureus* and *Escherichia coli*), and provides antioxidant protection. It is also believed to promote wound healing via collagen synthesis and tissue regeneration. Furthermore, it exhibits purifying and astringent qualities, which may help in sebum regulation and mattifying oily complexions. Emerging research points to a tyrosinase-blocking effect for skin depigmentation and influence on AhR and ARNT proteins, which are relevant in conditions like atopic dermatitis.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
This ingredient is commonly 'dusted' in formulations for its fragrance and perceived natural benefits. However, in vitro studies clearly indicate cytotoxicity to human skin cells at concentrations as low as 0.25%. Therefore, any concentration exceeding 0.125% in a topical formulation is considered a significant red flag due to potential cellular damage.
The Formula
Formulation
Stability
The primary constituents, linalool (~35%) and linalyl acetate (~50%), are prone to autoxidation when exposed to air, leading to the formation of potent contact allergens. This necessitates meticulous storage and packaging protocols to prevent oxidation. Despite this, it has shown stability in polypropylene homopolymer containers for two months across temperatures from 5 to 40°C, maintaining its physical and chemical integrity.
Safety
Safety Profile
While the U.S. FDA deems lavender generally recognized as safe (GRAS) for food, its status in cosmetics is not reviewed by CIR. The essential oil contains fragrant components (linalool, linalyl acetate) that autoxidize into strong contact allergens, leading to documented cases of hypersensitivity. In vitro research shows cytotoxicity to human skin cells at 0.25% (v/v), with concentrations up to 0.125% (v/v) being non-cytotoxic. Its use is discouraged for pregnant or breastfeeding individuals and children, and specifically not recommended during the first trimester of pregnancy. Although concerns about endocrine disruption have been raised, a recent review found no conclusive link in children based on current evidence. The EWG classifies it as 'Restricted' for its potential as an allergen.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Given its high irritancy potential, documented cytotoxicity to human skin cells above 0.125%, and significant sensitization risk, Moumoujus advises against the inclusion of LAVANDULA ANGUSTIFOLIA FLOWER OIL in precision skincare formulations despite some potential benefits.
Related
Similar Ingredients
Finding similar ingredients…